FOIA request to the U.S. Department of State seeking all records reflecting communications between senior officials and CureVac, a German company working to develop a coronavirus vaccine.

FOIA request to the U.S. Department of Treasury seeking all records reflecting communications between senior officials and CureVac, a German company working to develop a coronavirus vaccine.

FOIA request to the U.S. Department of Commerce seeking all records reflecting communications between senior officials and CureVac, a German company working to develop a coronavirus vaccine.

FOIA to the Centers for Disease Control and Prevention seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the National Institutes of Health seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the National Institute of Allergy and Infectious Diseases seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the Office of Management and Budget seeking communications regarding companies developing vaccines or treatments for coronavirus.

FOIA to the Food and Drug Administration (FDA) seeking records sufficient to identify the date Gilead submitted its request for orphan-drug designation for remdesivir as a treatment for COVID-19.

FOIA to the Food and Drug Administration seeking records sufficient to identify, with respect to requests for orphan-drug designation for treatments for COVID-19, the requester’s name, the date of the request, and the name of the treatment.

The Department of Labor stated that it had no records responsive to American Oversight's request for records reflecting a meeting between Mark Zelden, director of the Centers for Faith and Opportunity Initiatives, and Sedera Health executives.